Nexeon Medsystems Inc
| 1m | -48.19% |
| 3m | -51.29% |
| 6m | -33.41% |
| 1yr | +297.05% |
| 10d/3m | n/a |
| 52w High | n/a |
| 50d MA | n/a |
| 200d MA | n/a |
| Total Revenue | $m | n/a | n/a | n/a | 1.49 | 3.3 | 9.5 | 8.99 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps |
Profile Summary
Nexeon MedSystems, Inc. Is a bioelectronics company developing active medical devices for the treatment of cardiovascular disease. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, và cell biology. In addition, the Company is developing và commercializing NNS, an implantable neurostimulation & recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) & Pulsus Medical LLC.
Bạn đang xem: Nexeon medsystems inc
Directors
Last AnnualDecember 31st, 2017Last InterimSeptember 30th, 2018IncorporatedDecember 7th, 2015Public SinceAugust 1st, 2017
SectorHealthcare Equipment và SuppliesIndustryHealthcareExchange
As of Today at 18:15 UTC, shares in Nexeon Medsystems are trading at $0.15. This giới thiệu price information is delayed by 15 minutes.
Shares in Nexeon Medsystems last closed at $0.15 and the price had moved by +275.13% over the past 365 days. In terms of relative price strength the Nexeon Medsystems giới thiệu price has outperformed the S&P500 Index by +297.05% over the past year.
Xem thêm: Mốt Ăn Thịt Mèo Có Xui Không, Có Đen Không? Đi Ăn “Thần Dược” Xả Xui
The overall consensus recommendation for Nexeon Medsystems is Buy. You can view the full broker recommendation menu by unlocking its StockReport.
To buy shares in Nexeon Medsystems you'll need a share-dealing trương mục with an online or offline stock broker. Once you have opened your account & transferred funds into it, you'll be able to search and select shares to lớn buy và sell. You can use vtvplus.vn’s chia sẻ research software to lớn help you find the the kinds of shares that suit your investment strategy & objectives.
As of the previous close price of $0.15, shares in Nexeon Medsystems had a market capitalisation of .
Xem thêm: Trần Hoàng Phương Lan
Here are the trading details for Nexeon Medsystems:
Country of listing: United StatesExchange: PNKTicker Symbol: NXNNBased on an overall assessment of its quality, value và momentum Nexeon Medsystems is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental và technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, và Sucker Stocks. For more information, learn about our StockRank Styles.
